Clinical Studies & Publications

Do not use Florastor or other probiotics in any ICU setting and in those individuals with open arterial and venous access required (such as a Vascath, Permcath, or AV fistula).

Do not use for any individual with a central line or port or in the surroundings of any patient with a central line or port. [Central lines include short- and long-term central venous catheters (CVCs) and peripherally inserted central catheters (PICCs)].

Do not use Florastor for pre- or post- organ or bone marrow transplant patients and other patients considered severely immunocompromised or critically ill.

Do not use Florastor probiotics if allergic to any components (especially yeast). Less than 1% of patients experience constipation or thirst.

Very rarely, side effects such as: allergic reaction (skin rash). Fungemia or sepsis in patients with a central venous catheter, and in hospitalized, immunocompromised patients may occur.

For product questions or to report an adverse event, please call 877-356-7787.

This educational information is intended for use by qualified healthcare practitioners only and is not intended for use by consumers or to substitute for appropriate professional care.

Clinical studies suggest daily use of L-theanine 200 mg for at least 28 days for optimal stress and anxiety relief. Safe daily use up to 400 mg/day for up to 8 weeks; safety beyond this period is not established. Periodic assessment is advised. L-theanine may interact with antihypertensives and CNS depressants, potentially enhancing effects. Monitor patients for hypotension or sedation. Safety of L-theanine and probiotics in pregnancy, lactation, and individuals under 18 is not well established. Use should be based on clinical judgment. L-theanine may cause mild adverse effects such as metallic taste or dry mouth, typically resolving upon discontinuation. L-theanine is generally non-sedating, but individual response should be assessed, especially when combined with sedatives or alcohol. Probiotics may interact with immune-suppressing drugs. Probiotics should not be used in pre-/post-organ or bone marrow transplant patients or those who are severely immunocompromised or critically ill. Do not use in acute-care settings, in patients with open arterial/venous access (e.g., Vascath, Permcath, AV fistula), or around those with central lines (CVCs, PICCs). Though rare, probiotic supplementation carries a theoretical risk in immunocompromised patients or those with serious underlying conditions. Do not use if allergic to any components. Keep out of reach of children.

For product questions or to report an adverse event, please call 877-356-7787.

This educational information is intended for use by qualified healthcare professionals only and is not intended for use by consumers or to substitute for appropriate professional care.